Optimal sampling of antipsychotic medicines: a pharmacometric approach for clinical practice-Reference-Cited by-同舟云学术

Optimal sampling of antipsychotic medicines: a pharmacometric approach for clinical practice

Published:2014-09-19 Issue:4 Volume:78 Page:800-814
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Perera Vidya¹²,Bies Robert R.³⁴⁵,Mo Gary¹,Dolton Michael J.⁶,Carr Vaughan J.²⁷,McLachlan Andrew J.⁶,Day Richard O.⁸,Polasek Thomas M.⁹,Forrest Alan¹

Affiliation:

1. School of Pharmacy and Pharmaceutical Sciences; School of Pharmacy; SUNY at Buffalo; Buffalo NY USA

2. Schizophrenia Research Institute; Sydney Australia

3. Centre for Computational Biology and Bioinformatics; School of Medicine; Indiana University; Indianapolis IN USA

4. Division of Clinical Pharmacology; Indiana University School of Medicine; Indiana IN USA

5. Indiana Clinical and Translational Sciences Institute; Indiana IN USA

6. Faculty of Pharmacy; The University of Sydney; Sydney Australia

7. School of Psychiatry; University of New South Wales; Sydney Australia

8. Department of Clinical Pharmacology and Toxicology; St Vincent's Hospital; University of New South Wales; Sydney Australia

9. Department of Clinical Pharmacology; Flinders University; Adelaide Australia

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12410/fullpdf

Reference70 articles.

1. Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study;Stroup;Am J Psychiatry,2007

2. Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients;Maloney;Neuropsychiatr Dis Treat,2010

3. Population pharmacokinetics of antipsychotics

4. Reasons for discontinuation and continuation of antipsychotics in the treatment of schizophrenia from patient and clinician perspectives;Ascher-Svanum;Curr Med Res Opin,2010

5. Time to discontinuation of first- and second-generation antipsychotic medications in the treatment of schizophrenia;Kreyenbuhl;Schizophr Res,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between olanzapine plasma concentrations and treatment response: A systematic review, meta-analysis and individual participant data meta-analysis;Biomedicine & Pharmacotherapy;2024-03

2. Optimizing the design of a pharmacokinetic trial to evaluate the dosing scheme of a novel tuberculosis drug in children living with or without HIV;CPT: Pharmacometrics & Systems Pharmacology;2023-11-17

3. Bayesian optimization of tacrolimus exposure in stable kidney transplant patients;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-07-23

4. Population pharmacokinetic model and limited sampling strategy for clozapine using plasma and dried blood spot samples;Therapeutic Advances in Psychopharmacology;2022-01

5. Antipsychotic polypharmacy in schizophrenia: evolving evidence and rationale;Expert Opinion on Drug Metabolism & Toxicology;2020-09-28